LSA
NVO

Leonteq Securities AG’s Novo Nordisk NVO Stock Holding History

Leonteq Securities AG’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
28,796
-124,447
-81% -$5.35M 0.05% 223
2026
Q1 		$5.63M Buy
+153,243
New +$7.26M 0.21% 88
2025
Q4 		– Sell
-179,680
Closed -$9.19M – 1499
2025
Q3 		$9.97M Sell
179,680
-140,500
-44% -$8.22M 0.3% 61
2025
Q2 		$22.1M Buy
320,180
+201,209
+169% +$13.7M 0.85% 23
2025
Q1 		$8.26M Sell
118,971
-2,018
-2% -$167K 0.46% 35
2024
Q4 		$10.4M Buy
120,989
+86,142
+247% +$9.32M 0.7% 23
2024
Q3 		$4.15M Buy
34,847
+19,555
+128% +$2.61M 0.32% 70
2024
Q2 		$2.18M Buy
15,292
+2,352
+18% +$312K 0.15% 122
2024
Q1 		$1.66M Buy
12,940
+9,485
+275% +$1.13M 0.12% 174
2023
Q4 		$357K Buy
3,455
+745
+27% +$73.7K 0.02% 386
2023
Q3 		$246K Buy
2,710
+1,200
+79% +$106K 0.01% 481
2023
Q2 		$122K Buy
+1,510
New +$123K 0.01% 636
2023
Q1 		– Sell
-2
Closed -$135 – 1290
2022
Q4 		$135 Hold
2
– – ﹤0.01% 1258
2022
Q3 		$100 Hold
2
– – ﹤0.01% 1254
2022
Q2 		$111 Hold
2
– – ﹤0.01% 1255
2022
Q1 		$111 Sell
2
-800
-100% -$41.1K ﹤0.01% 1221
2021
Q4 		$44.9K Buy
802
+700
+686% +$37.9K ﹤0.01% 923
2021
Q3 		$4.9K Sell
102
-214
-68% -$10.3K ﹤0.01% 1080
2021
Q2 		$13.2K Sell
316
-712
-69% -$27.6K ﹤0.01% 983
2021
Q1 		$34.7K Sell
1,028
-24,116
-96% -$859K ﹤0.01% 821
2020
Q4 		$878K Buy
+25,144
New +$869K 0.05% 307

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Leonteq Securities AG's NVO Position: Q2 2026 in Review

Leonteq Securities AG reduced its Novo Nordisk (NVO) stake by 81% in Q2 2026, selling an estimated $5.35M and leaving 28,796 shares worth $1.38M. The position accounts for 0.05% of the portfolio, ranked #223.

Leonteq Securities AG first reported a position in NVO in Q4 2020 and has held it in 21 quarters since. The position peaked at $22.1M in Q2 2025. 1,346 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Leonteq Securities AG held 28,796 shares of Novo Nordisk worth $1.38M as of Q2 2026.
  • Leonteq Securities AG sold 124,447 Novo Nordisk shares in Q2 2026, an estimated $5.35M.
  • Novo Nordisk made up 0.05% of Leonteq Securities AG's portfolio in Q2 2026, its #223 holding.
  • Leonteq Securities AG first reported a position in Novo Nordisk in Q4 2020 and has held it in 21 quarters since.
  • Leonteq Securities AG's Novo Nordisk position peaked at $22.1M in Q2 2025.
  • 1,346 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.